medicalnewstoday.com
Minister Wallace Announces Date For Removal Of All Point-Of-Sale Advertising For Tobacco Products
11.07.2008 05:15
medicalnewstoday.com
Ms Mary Wallace T.D., Minister of State at the Department of Health and Children with special responsibility for Health Promotion and Food Safety, announced that further provisions of the Public Health (Tobacco) Acts 2002 and 2004 are to be commenced on 1 July 2009.
World
Smoking
TR BioSurgical Commercializes Breakthrough Tissue Repair BioScaffold
11.07.2008 05:15
medicalnewstoday.com
TR BioSurgical, LLC, a veterinary biomaterials company, announced they have commercialized a breakthrough medical device scaffold called TR Matrix™. TR Matrix consists of collagen that has been engineered into a unique, open polar structure that mimics early stage connective tissue.
World
Medical Equipment
BioCryst Announces Initiation Of Phase II Study Of Intramuscular Peramivir For The Treatment Of Seasonal Influenza
11.07.2008 05:15
medicalnewstoday.com
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced the initiation of a Phase II study of intramuscular (i.m.) peramivir for the treatment of seasonal influenza. The double-blind, placebo-controlled, parallel group Phase II trial will compare the efficacy of a single 600 mg injection of i.m. peramivir to placebo in the treatment of seasonal influenza.
World
SARS
Modigene Platform Validated In Independent Phase III Trial Of CTP Technology
11.07.2008 05:15
medicalnewstoday.com
Modigene Inc., (OTC Bulletin Board: MODG) noted the successful completion of a Phase III clinical trial by Schering-Plough of long-acting fertility hormone corifollitropin alfa (FSH-CTP). FSH-CTP uses the naturally occurring CTP peptide to extend the duration of action of the hormone. Modigene is using the same naturally occurring CTP peptide to extend the duration of action of other therapeutic proteins and peptides.
World
Endocrinology
VIA Pharmaceuticals Completes Patient Visits In Phase 2 Carotid Endarterectomy (CEA) Trial
11.07.2008 05:14
medicalnewstoday.com
VIA Pharmaceuticals, Inc. (Nasdaq: VIAP), a biotechnology company focused on the development of compounds for the treatment of cardiovascular disease, announced that it has completed the last patient visit in its carotid endarterectomy (CEA) study. The excised carotid plaque tissue will be analyzed to determine VIA-2291's effect on inflammation, and the company remains on track to report top-line data in the third quarter.
World
Cardiology
Proteolix Initiates Phase 1b Clinical Trial Of Carfilzomib In A Combination Regimen For Patients With Relapsed Multiple Myeloma
11.07.2008 05:14
medicalnewstoday.com
Proteolix, Inc. announced that patient dosing has commenced in a Phase 1b clinical trial to evaluate the safety and efficacy of Proteolix's lead anti-cancer agent, carfilzomib (PR-171), in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma. Carfilzomib selectively blocks proteasome activity, causing apoptosis in cancer cells.
World
Cancer
Pseudotumours Risk For Hip Resurfacing Highlights Need For Regular Clinical Follow-up For New Devices
11.07.2008 05:14
medicalnewstoday.com
As the incidence of metal-on-metal hip resurfacing has increased in recent years, especially in younger patients, research published in the Journal of Bone and Joint Surgery - British Volume (JBJS-Br) discusses occurrences of "pseudotumours" as a result. The researchers estimate that approximately 1% of patients who have metal-on-metal hip resurfacings develop pseudotumours within five years of treatment.
World
Orthopedics
Protelos(R) (Strontium Ranelate) Is The First Osteoporosis Treatment To Demonstrate Long-term Reduced Risk Of Hip Fracture
11.07.2008 05:14
medicalnewstoday.com
Results of a new study published in the latest edition of leading journal Arthritis and Rheumatism confirm a long-term reduction in the risk of fractures with strontium ranelate in post menopausal women with osteoporosis. The trial, which studied the efficacy of strontium ranelate over a five year period, showed significant reductions of up to 43% (p
World
Orthopedics
Protelos(R) (strontium Ranelate) Is The First Osteoporosis Treatment To Demonstrate Long-term Reduced Risk Of Hip Fracture
11.07.2008 05:14
medicalnewstoday.com
Results of a new study published in the latest edition of leading journal Arthritis and Rheumatism confirm a long-term reduction in the risk of fractures with strontium ranelate in post menopausal women with osteoporosis. The trial, which studied the efficacy of strontium ranelate over a five year period, showed significant reductions of up to 43% (p
World
Orthopedics
Autism Could Be Caused By Failure To Trigger Genes In Early Brain Development
11.07.2008 05:14
medicalnewstoday.com
An international team of scientists studying genetic causes of autism spectrum disorders by focusing on families where both parents shared a recent ancestor, found that seemingly diverse genes linked to autism had something in common in that many were triggered by by brain development that is regulated by early childhood experience.
World
Autism
Minister Moloney Welcomes The Increase In Funding For The Dementia Unit In St. Vincent's Hospital, Mountmellick, Ireland
11.07.2008 05:14
medicalnewstoday.com
Minister Moloney welcomes the increase in funding for the Dementia Unit in St. Vincent's Hospital, Mountmellick. John Moloney T.D., Minister for Disability and Mental Health at the Department of Health and Children, welcomed confirmation that funding of â?¬350k (â?¬700k full year) has been made available to recruit the core staff required for the new Dementia Unit in St. Vincent's Hospital, Mountmellick.
World
Alzheimer's Disease
California Wildfires: Protecting Your Health
11.07.2008 05:14
medicalnewstoday.com
As hundreds of wildfires continue to burn across California, residents are dealing with smoke and dust pollution. Smoke, dust and fire can have negative effects on anyone in the area, including emergency responders and relief workers. All are likely to encounter one or more of these dangerous elements. It is vitally important to follow the instructions of local officials regarding evacuation and risk area information.
World
First Aid
Obese Men Have Less Semen, More Sperm Abnormalities, And Should Lose Weight Before Trying For A Baby
11.07.2008 04:14
medicalnewstoday.com
Obese men should consider losing weight if they want to have children, a scientist told the 24th annual conference of the European Society of Human Reproduction and Embryology. Dr. A Ghiyath Shayeb, from the University of Aberdeen, Aberdeen, UK, said that his research had shown that men with a higher body mass index (BMI) had lower volumes of seminal fluid and a higher proportion of abnormal sperm. Dr.
World
Weight Correction
HIV Prevention Researchers To Compare Common ARV As A Pill And Vaginal Gel In Unique Study
11.07.2008 04:13
medicalnewstoday.com
In battle with an epidemic that has outpaced nearly all efforts to contain it, researchers are turning to strategies centered on the same antiretroviral (ARV) drugs that have been used successfully to treat HIV in hopes they will be as effective a stronghold for preventing the virus.
World
HIV/AIDS
Want To Keep Your Privacy? "No Med Exam" Life Insurance Now Available
11.07.2008 04:13
medicalnewstoday.com
Now available is a term life insurance policy from 420lifeinsurance.com that allows individuals to get a quality plan while keeping their privacy. A lot of Americans are without life insurance because of fears dealing with their existing health conditions that typically raise rates.
World
Insurance
English